In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa

被引：4
|
作者：
Solak, S
Willke, A
Ergönül, Ö
Tekeli, E
机构：
[1] Kocaeli Univ, Dept Clin Bacteriol & Infect Dis, Fac Med, Kocaeli, Turkey
[2] Ankara Numune Training & Res Hosp, Dept Clin Microbiol & Infect Dis, Ankara, Turkey
[3] Ankara Univ, Fac Med, Dept Clin Bacteriol & Infect Dis, Ankara, Turkey
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2005年 / 25卷 / 02期
关键词：
D O I：
10.1016/j.ijantimicag.2004.11.005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [1] In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa
    GarciaRodriguez, JA
    Blazquez, AM
    Fresnadillo, MJ
    Sanchez, EG
    Sanchez, JEG
    Martin, IT
    [J]. JOURNAL OF CHEMOTHERAPY, 1996, 8 (05) : 358 - 364
  • [2] An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa
    Segatore, Bernardetta
    Perilli, Mariagrazia
    Larosa, Monica
    Setacci, Domenico
    Celenza, Giuseppe
    Amicosante, Gianfranco
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (04) : 374 - 376
  • [3] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Yi-Fan Hu
    Chang-Pan Liu
    Nai-Yu Wang
    Shou-Chuan Shih
    [J]. BMC Infectious Diseases, 16
  • [4] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Hu, Yi-Fan
    Liu, Chang-Pan
    Wang, Nai-Yu
    Shih, Shou-Chuan
    [J]. BMC INFECTIOUS DISEASES, 2016, 16
  • [5] In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with β-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia
    Isenberg, HD
    Alperstein, P
    France, K
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) : 81 - 86
  • [6] In vitro activity of fosfomycin, alone or in combination, against clinical isolates of carbapenem resistant Pseudomonas aeruginosa
    Gomez-Garces, Jose-Luis
    Gil-Romero, Yolanda
    Sanz-Rodriguez, Nuria
    Munoz-Paraiso, Carmen
    Regodon-Dominguez, Marta
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 (04): : 228 - 231
  • [7] Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
    Pankuch, Glenn A.
    Lin, Gengrong
    Seifert, Harald
    Appelbaum, Peter C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) : 333 - 336
  • [8] In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains
    Erdem, I
    Kucukercan, M
    Ceran, N
    [J]. CHEMOTHERAPY, 2003, 49 (06) : 294 - 297
  • [9] ACTIVITY IN-VITRO OF MEROPENEM AGAINST CLINICAL ISOLATES
    ZANETTI, S
    JULIANO, C
    SECHI, L
    ANGIOI, A
    GAVINI, E
    PIRINA, P
    FADDA, G
    [J]. JOURNAL OF CHEMOTHERAPY, 1993, 5 : 121 - 122
  • [10] Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates
    Zahra, Momeni-Javid
    Hamed, Hamishekar
    Mohammad, Rahmati-Yamchi
    Nosratollah, Zarghami
    Akbarzadeh, Abolfazl
    Morteza, Milani
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2017, 45 (05) : 975 - 980
12345